Paroxysmal nocturnal hemoglobinuria (PNH) analysis (CD55 and CD59) is a laboratory test used to determine the levels of CD55 and CD59 proteins on the surface of red blood cells. These proteins play a vital role in protecting cells from immune-mediated destruction. This test is usually performed to diagnose paroxysmal nocturnal hemoglobinuria, a rare disorder characterized by increased breakdown of red blood cells, leading to anemia. A blood sample is collected and analyzed to determine the proportion of these proteins, helping physicians assess the condition and guide appropriate treatment. This analysis is important in disease management, as it can help reduce the health risks associated with severe anemia.